Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms
R Zhu, T Yan, Y Feng, Y Liu, H Cao, G Peng, Y Yang… - Cell research, 2021 - nature.com
The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …
Mesenchymal stem cell therapy for COVID-19: present or future
Abstract “COVID-19” is the word that certainly isn't forgotten by everybody who lives in the
first half of the twenty-first century. COVID-19, as a pandemic, has led many researchers …
first half of the twenty-first century. COVID-19, as a pandemic, has led many researchers …
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
W Yao, L Shi, Y Zhang, H Dong, Y Zhang - Stem Cell Research & Therapy, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …
Bone marrow-derived mesenchymal stromal cell therapy in severe COVID-19: preliminary results of a phase I/II clinical trial
C Grégoire, N Layios, B Lambermont… - Frontiers in …, 2022 - frontiersin.org
Background Treatment of acute respiratory distress syndrome (ARDS) associated with
COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and supportive …
COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and supportive …
Mesenchymal stem cell therapy for severe COVID-19
L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …
(COVID-19) became a serious endangerment to human health and the causal agent of a …
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
N Kaffash Farkhad, A Sedaghat, H Reihani… - Stem Cell Research & …, 2022 - Springer
Background Acute respiratory distress syndrome (ARDS) is the devastating complication of
the new COVID-19 pandemic, directly correlated with releasing large amounts of …
the new COVID-19 pandemic, directly correlated with releasing large amounts of …
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
M Karyana, I Djaharuddin, L Rif'ati, M Arif… - Stem cell research & …, 2022 - Springer
Background Due to their immunomodulatory properties, mesenchymal stem cells (MSCs)
have been proposed to have therapeutic potential to improve clinical outcomes in COVID …
have been proposed to have therapeutic potential to improve clinical outcomes in COVID …
[HTML][HTML] Mesenchymal stem cell treatment for COVID-19
R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …
global pandemic since late 2019 that resulted in more than 360 million population infection …
[HTML][HTML] Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia
AK Shetty - Aging and disease, 2020 - ncbi.nlm.nih.gov
A new study published by the journal Aging & Disease reported that intravenous
administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with …
administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with …